NCT00791557 Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT00790933 An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease Status COMPLETED Phase PHASE3
NCT00787202 A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis. Status COMPLETED Phase PHASE2
NCT00783718 Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00783575 Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease Status WITHDRAWN Phase N/A
NCT00769353 Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness Status COMPLETED Phase NA
NCT00767728 Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00751933 Vaccines and Dietary Oats in the Treatment of Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT00744016 Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00737789 Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis. Status COMPLETED Phase PHASE3
NCT00727324 Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT00713310 Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT00702611 Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis Status TERMINATED Phase PHASE4